Microtubule Inhibitor class drugs
5 results
Eribulin mesylate (eribulin mesylate)
(Eribulin Mesylate)Baxter Healthcare Corporation
Usage: Eribulin Mesylate Injection is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapy regimens, including an anthracycline and a taxane. It is also indicated for unresectable or metastatic liposarcoma in patients previously treated with an anthracycline-containing regimen.
Halaven (eribulin mesylate)
(eribulin mesylate)BSP Pharmaceuticals SpA
Halaven (eribulin mesylate)
(eribulin mesylate)Eisai Inc.
Usage: HALAVEN is indicated for patients with metastatic breast cancer who have received at least two prior chemotherapy regimens, including an anthracycline and a taxane. It is also used for unresectable or metastatic liposarcoma after a prior anthracycline-containing regimen.
Ixempra (ixabepilone)
(ixabepilone)R-Pharm US Operating, LLC
Usage: IXEMPRA is indicated for treating metastatic or locally advanced breast cancer in combination with capecitabine for patients resistant to anthracyclines and taxanes. It is also approved as a single agent for patients whose tumors are resistant to anthracyclines, taxanes, and capecitabine.
Klisyri (tirbanibulin)
(tirbanibulin)Almirall, LLC
Usage: KLISYRI is indicated for the topical treatment of actinic keratosis on the face or scalp.